Privia Health Group (NASDAQ:PRVA) Price Target Raised to $28.00

Privia Health Group (NASDAQ:PRVA) had its target price boosted by JPMorgan Chase & Co. from $27.00 to $28.00 in a research report sent to investors on Friday,Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other equities research analysts also recently commented on the company. KeyCorp assumed coverage on Privia Health Group in a research report on Friday, October 11th. They set an “overweight” rating and a $23.00 price objective for the company. Robert W. Baird upped their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, August 26th. Truist Financial lifted their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Barclays boosted their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a report on Friday, November 8th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $28.00 price objective on shares of Privia Health Group in a research note on Wednesday, August 14th. Two analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Buy” and an average price target of $24.93.

Privia Health Group Trading Down 0.8 %

Shares of Privia Health Group stock opened at $21.48 on Friday. The company’s 50-day moving average price is $19.24 and its two-hundred day moving average price is $18.70. The stock has a market cap of $2.58 billion, a PE ratio of 214.82, a price-to-earnings-growth ratio of 5.40 and a beta of 0.76. Privia Health Group has a 52 week low of $15.92 and a 52 week high of $24.30.

Insider Buying and Selling

In other Privia Health Group news, CEO Parth Mehrotra sold 135,142 shares of the company’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the sale, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at approximately $4,583,763.50. This represents a 35.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 14.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of PRVA. Canada Pension Plan Investment Board bought a new position in shares of Privia Health Group during the 2nd quarter valued at about $26,000. GAMMA Investing LLC grew its position in shares of Privia Health Group by 98.7% during the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock worth $31,000 after purchasing an additional 845 shares in the last quarter. Nisa Investment Advisors LLC increased its stake in Privia Health Group by 107.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock worth $31,000 after acquiring an additional 930 shares during the period. Signaturefd LLC raised its stake in Privia Health Group by 46.3% in the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after purchasing an additional 626 shares in the last quarter. Finally, Quarry LP lifted its holdings in shares of Privia Health Group by 344.6% during the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock worth $60,000 after acquiring an additional 2,533 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.